RXO, Inc. Files 8-K Report

TL;DR

RXO filed a routine 8-K, no major news.

AI Summary

On October 22, 2024, RXO, Inc. filed an 8-K report to disclose other events and financial statements. The filing does not contain specific financial figures or significant business updates beyond its routine reporting nature.

Why It Matters

This filing indicates RXO, Inc. is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no indication of material changes or risks.

Key Players & Entities

• RXO, Inc. (company) — Registrant
• October 22, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 11215 North Community House Road, Charlotte, NC 28277 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ich registered Common stock, par value $0.01 per share RXO New York Stock Exchan

Filing Documents

• ny20037476x2_8k.htm (8-K) — 28KB
• ny20037476x2_ex5-1.htm (EX-5.1) — 15KB
• 0001140361-24-043904.txt ( ) — 179KB
• rxo-20241022.xsd (EX-101.SCH) — 4KB
• rxo-20241022_lab.xml (EX-101.LAB) — 21KB
• rxo-20241022_pre.xml (EX-101.PRE) — 16KB
• ny20037476x2_8k_htm.xml (XML) — 4KB

01

Item 8.01 Other Events. On October 22, 2024, RXO, Inc. (the "Company") filed with the Securities and Exchange Commission a prospectus supplement to the prospectus included in the Company's registration statement on Form S-3ASR (File No. 333-282002) (the "Registration Statement"), covering the resale by certain selling stockholders named therein of an aggregate of 28,514,952 shares of the Company's common stock, consisting of (i) 22,255,481 shares of common stock outstanding and (ii) 6,259,471 shares of common stock issuable upon the exercise of pre-funded warrants to purchase common stock. A copy of the legal opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP relating to the shares is filed herewith as Exhibit 5.1 and is incorporated herein by reference, and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP. 23.1 Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. RXO, INC. Date: October 22, 2024 By: /s/ Jeffrey D. Firestone Jeffrey D. Firestone Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR